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ABSTRACT The cardiac L-type voltage-dependent calcium channel is responsible for initiating excitation-contraction
coupling. Three sequences (amino acids 1609–1628, 1627–1652, and 1665–1685, designated A, C, and IQ, respectively) of its
a1 subunit contribute to calmodulin (CaM) binding and Ca
21-dependent inactivation. Peptides matching the A, C, and IQ
sequences all bind Ca21CaM. Longer peptides representing A plus C (A-C) or C plus IQ (C-IQ) bind only a single molecule of
Ca21CaM. Apocalmodulin (ApoCaM) binds with low afﬁnity to the IQ peptide and with higher afﬁnity to the C-IQ peptide. Binding
to the IQ and C peptides increases the Ca21 afﬁnity of the C-lobe of CaM, but only the IQ peptide alters the Ca21 afﬁnity of the
N-lobe. Conversion of the isoleucine and glutamine residues of the IQ motif to alanines in the channel destroys inactivation
(Zu¨hlke et al., 2000). The double mutation in the peptide reduces the interaction with apoCaM. A mutant CaM unable to bind
Ca21 at sites 3 and 4 (which abolishes the ability of CaM to inactivate the channel) binds to the IQ, but not to the C or A peptide.
Our data are consistent with a model in which apoCaM binding to the region around the IQ motif is necessary for the rapid
binding of Ca21 to the C-lobe of CaM. Upon Ca21 binding, this lobe is likely to engage the A-C region.
INTRODUCTION
Calmodulin (CaM) is an important regulator of ion channels,
serving as a Ca21 sensor for a number of ligand- and voltage-
gated ion channels (Saimi and Kung, 2002). The cardiac
L-type voltage-dependent calcium channel (Cav1.2) is the
cardiac isoform of the L-type voltage-dependent calcium
channel, but is also found in a variety of other tissues. The
binding of Ca21 to CaM, bound to the carboxy-terminal tail
of the a1 subunit of the CaV1.2 channel, can enhance channel
opening (facilitation) (Zu¨hlke et al., 1999), accelerate
channel closing (inactivation) (Peterson et al., 1999; Qin
et al., 1999), and/or initiate changes in gene transcription by
activating the neuronal MAPK pathway (Dolmetsch et al.,
2001). The molecular details of the processes by which CaM
performs such diverse functions are not clear. The amplitude
and/or frequency of the Ca21 signal itself and/or the
functional state of the channel at the time of the change in
the Ca21 concentration may contribute to the functional
outcome of Ca21 binding to CaM bound to the channel.
In cardiac muscle, Ca21-dependent inactivation of the
CaV1.2 channel occurs during maintained depolarizations
(Catterall, 2000; McDonald et al., 1994). Both Ca21 inﬂux
through the Ca21 channel and CaM binding to a motif
designated as IQ are required for this type of inactivation
(Peterson et al., 1999). Other sequences within the channel
also appear to contribute to the inactivation event. The I–II
loop (Adams and Tanabe, 1997), the putative Ca21 binding
EF hand motif (Zu¨hlke and Reuter, 1998), and several
regions between the EF hand and the IQ motif (Pate et al.,
2000; Peterson et al., 2000; Pitt et al., 2001; Soldatov et al.,
1998) have been implicated in this process. Ca21-dependent
inactivation is blocked by a mutant CaM that cannot bind
Ca21, suggesting that the channel also binds apocalmodulin
(ApoCaM or Ca21 free CaM) (Peterson et al., 1999).
Channel facilitation is a phenomenon in which Ca21
currents are enhanced after an increase in basal Ca21 or
repeated transient depolarizations (Anderson, 2001). CaM
binding to the IQ motif is required for this process, since
mutation of the isoleucine to a glutamate destroys CaM
binding completely and abolishes both inactivation and
facilitation (Zu¨hlke et al., 1999). Mutation of the isoleucine
(amino acid 1624) within this sequence to an alanine results in
loss of Ca21-dependent inactivation and unmasks a strong
facilitation by CaM (Zu¨hlke et al., 1999, 2000). Mutation (IQ
(AA)) of both the isoleucine and the glutamine to an alanine
(I1624A/Q1625A) produces an evenmore pronounced facili-
tation and, again, abolishes inactivation (Zu¨hlke et al., 2000).
Three different sequences in a1C carboxyterminal tail of
Cav1.2 have been suggested to contribute directly to CaM
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binding (Pate et al., 2000; Pitt et al., 2001; Soldatov et al.,
1998; Zu¨hlke and Reuter, 1998). These sequences are amino
acids 1609–1628 (Pitt et al., 2001; Soldatov et al., 1998),
1627–1652 (Pate et al., 2000; Pitt et al., 2001), and 1665–
1685 (Pate et al., 2000; Soldatov et al., 1998; Zu¨hlke and
Reuter, 1998) (this numbering is that of the human cardiac
sequence), designated A, C, and IQ, respectively. Synthetic
peptides representing these sequences all bind Ca21CaM,
but it is not clear how they together contribute to CaM
binding to the channel. The Amotif (amino acids 1565–1578
of the mouse sequence or 1609–1628 of the human se-
quence) represents a 1-8-14 CaM binding motif (Pitt et al.,
2001). Pitt and co-workers proposed that the N-lobe of
apoCaM binds to the A motif whereas the C-lobe binds at
an unidentiﬁed site, providing a ‘‘brake’’ that slows inacti-
vation. In this model, when Ca21 enters via the channel, it
binds to the C-lobe of CaM, allowing this lobe of CaM to
bind to the IQ motif, producing inactivation. This model
predicts an apoCaM binding site in the carboxyterminal tail
with the A motif forming part of the binding site. An
apoCaM site has not been identiﬁed. However, an expressed
fragment of the carboxyterminal tail corresponding to amino
acids 1551–1660 of the mouse sequence (human sequence
1599–1708) that includes the A, C, and IQ sequences appears
to undergo a Ca21-dependent conformational change (Pitt
et al., 2001). The binding of Ca21 with nM afﬁnity at some
site within this sequence is thought to alter the conformation
of this region of the carboxyterminal tail to allow apoCaM
binding. Romanin et al. (2000) found that the mouse se-
quence 1571–1586 (human 1619–1634) represents a high
afﬁnity Ca21 binding site. The Ca21 dependence of the
interaction of CaM with the carboxyterminal tail of the
CaV1.2 channel, therefore, appears to arise from Ca
21
binding to both CaM and the channel itself. The afﬁnity of
the Ca21 binding site on the channel is such that Ca21 is
likely to occupy this site at resting Ca21 levels.
How these three regions of the CaV1.2 channel allow CaM
to function as a Ca21 sensor for inactivation remains to be
answered. We compared the ability of synthetic peptides
representing the A, C, and IQ motifs to bind Ca21CaM,
apoCaM, and Ca21 binding site mutants of CaM and to alter
the Ca21 binding properties of CaM. We also examined the
interaction of CaM with a peptide containing the IQ to AA
substitution that abolishes Ca21-dependent inactivation of
this channel.
MATERIALS AND METHODS
Materials
Bovine brain CaM (95% pure) was purchased from Sigma (St. Louis, MO)
and dissolved in 10 mM MOPS (pH 7.4), 1 mM EGTA, and 0.02% NaN3.
CaMs with engineered mutations were constructed and isolated as described
by Black et al. (2000). All peptides were synthesized at the protein lab
facility at Baylor College of Medicine and were diluted into 200 mMMOPS
(pH 7.4). Table 1 lists the peptides that are used in this study. All
electrophoresis reagents were analytical grade from BioRad (Hercules, CA).
Methods
Electrophoretic mobility shift assays
The interactions of CaM with the peptides were evaluated by nondenaturing
PAGE, under discontinuous conditions using a modiﬁed Laemmli technique
(Laemmli, 1970). For analysis of interaction at low Ca21 concentrations, the
gels were prepared in triplicate with 1 mM EGTA in all solutions. CaM
(2 mM) in either 200 mM free Ca21 or 1 mM EGTA was incubated with the
peptides in molar ratios of peptide:CaM of 0.1:1, 0.5:1, 1:1, 2:1, 3:1, 5:1, and
10:1. The extent of the interaction was quantiﬁed by densitometer analysis of
Coomassie-stained gels of the uncomplexed CaM at each peptide:CaM
molar ratio. Values were normalized to CaM in the absence of peptide. Mean
normalized optical density values mean 6 SE were plotted as a function of
peptide:CaM ratio.
SDS PAGE
Polyacrylamide gel electrophoresis was performed as described by Laemmli
(1970) or Scha¨gger and von Jagow (1987). The latter gels are designated
Scha¨gger gels in this article.
Native to denatured two-dimensional gel electrophoreses
To determine the composition of the complexes detected by nondenaturing
gel electrophoresis, lanes from the nondenaturing gel containing the CaM-
peptide complex were excised. The gel strip was then loaded on top of
a Scha¨gger polyacrylamide gel for the second-dimension electrophoresis.
The gap between the gel strip and the second-dimension resolving gel was
sealed with melted agarose (1% agarose, 2% SDS, and 50 mMDTT) and the
gels were electrophoresced for 1–2 h at 120–170V at 48C. The two-
dimensional gels were subsequently stained with Coomassie blue (R250).
Ca21 afﬁnity determination
Ca21 afﬁnity was determined using standardized Ca21 solutions from
Molecular Probes (Eugene, OR) composed of 30 mM MOPS (pH 7.2), 100
TABLE 1 Sequences of the CaV1.2 channel a1 carboxy-terminal peptides
Peptide Seq. no. Human Amino acids
A 1609–1628 TLFALVRTALRIKTEGNLEQ
C 1627–1652 EQANEELRAIIKKIWKRTSMKLLDQV
IQ 1665–1685 KFYATFLIQEYFRKFKKRKEQ
A-C 1609–1653 TLFALVRTALRIKTEGNLEQANEELRAIIKKIWKRTSMKLLDQVV
C-IQ 1627–1685 EQANEELRAIIKKIWKRTSMKLLDQVVPPAGDDEVTVGKFYATFLIQEYFRKFKKRKEQ
IQW 1665–1685 KWYATFLIQEYFRKFKKRKEQ
IQ (AA) 1665–1685 KFYATFLAAEYFRKFKKRKEQ
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mM KCl, 10 mM EGTA, and various Ca21 concentrations. CaM (2.5 mM)
and the speciﬁed channel peptide (10 mM) were incubated at room
temperature. Tryptophan ﬂuorescence was measured at 330 nm after 295-nm
excitation. Each EC50 reported represents an average of 3–5 replicate
titrations, mean 6 SE.
CaM binding analysis by ﬂuorescence
Assays of the interactions of CaM with the peptides by tryptophan
ﬂuorescence were performed in either a high Ca21 buffer or a low Ca21
buffer. The high Ca21 buffer contained 1 mMEGTA, 300 mMNaCl, 50 mM
MOPS at pH 7.4, 0.1% CHAPS, 100 mg/ml bovine serum albumin, 1.2 mM
CaCl2, and 0.02% NaN3. Low Ca
21 buffer contains 1 mM EGTA, 300 mM
NaCl, 50 mM MOPS pH 7.4, 0.1% CHAPS, 100 mg/ml bovine serum
albumin, and 0.02%NaN3. Peptides (10 mM) with or without CaM (2.5 mM)
were incubated on an Orbit-P4 shaker in a 96 well Molecular Probes quartz
plate at 25 rpm for 30 min before scanning. Fluorescence spectra were
obtained on a SpectraMAX Gemini ﬂuorometer (Molecular Devices,
Sunnyvale, CA). We used four different excitation/emission protocols on
all samples: 1) excitation at 295 nM and emission at 330 nm; 2) excitation at
275 nm and emission at 320 nm; 3) excitation at 295 nm and emission
scanning from 310 nm to 400 nm; and 4) excitation at 275 nm and emission
scanning from 310 nm to 400 nm. All experiments were done in triplicate and
data are presented as a mean6 SE. Binding interactions produced blue shifts
in the peak ﬂuorescence accompanied by increases in ﬂuorescence intensity.
Ca21 afﬁnities determined by excitation at 295 nm were not statistically
different from those determined by 275-nm excitation, despite the
contribution of phenylalanine and tyrosine ﬂuorescence with the latter
protocol. Data shown in ﬁgures were obtained from the 295-nm excitation.
RESULTS
Peptides representing sequences within the
a1 carboxy-terminal tail differentially interact
with Ca21CaM and apoCaM
Three different sequences have been implicated in Ca21CaM
binding to the carboxyterminal tail of the CaV1.2 channel.
We compared the ability of synthetic peptides matching
these sequences to bind Ca21CaM. The peptides, listed in
Table 1, fall into three categories: 1) peptides exactly
matching the sequences within the carboxyterminal tail of
the cardiac CaV1.2 channel (A, C, IQ, A-C, and C-IQ), 2)
a peptide (IQW) prepared with a tryptophan in place of
phenylalanine 1666 to allow us to monitor binding of CaM to
the peptide by changes in the tryptophan ﬂuorescence of the
peptide, and 3) a peptide with amino acid substitutions
corresponding to the mutations that destroyed Ca21-de-
pendent inactivation (IQ (AA)) (Zu¨hlke et al., 1999, 2000).
To determine the apparent afﬁnity of the peptides for
CaM, the peptides were incubated with CaM at several dif-
ferent peptide:CaM ratios and electrophoresced on non-
denaturing gels. Fig. 1 A shows the nondenaturing gels of
Ca21CaM in the presence of increasing concentrations of
each of these peptides. The summarized data from the den-
sitometer analyses of replicate gels for all the peptides are
shown in Fig. 1 C. In this gel system the peptide alone does
not enter the gel due to its positive charge. In the high Ca21
gels the complex of the peptide and CaM can be seen above
the free CaM band. All of the peptides tested bind Ca21CaM.
Both IQ (AA) and IQW (data not shown) bind Ca21CaMwith
the same apparent afﬁnity as the IQ peptide.
The ability of a Ca21 binding site mutant of CaM to block
Ca21-dependent inactivation (Peterson et al., 1999) suggests
that the CaV1.2 Ca
21 channel binds both apoCaM and
Ca21CaM. Although apoCaM binding to the carboxyl tail
has been suggested by Peterson et al. (1999) and Pitt et al.
(2001), an actual apoCaM binding site has not been
demonstrated. In the nondenaturing gel system, apoCaM
binding was detected to the IQ, IQW (data not shown), and
C-IQ peptides (Fig. 1 B). The summarized data from the
densitometer analyses of replicate gels for all the peptides
are shown in Fig. 1 D (low Ca21). In the low Ca21 gels, the
CaM-peptide complex does not migrate as a discrete band,
consistent with previous observations (Pate et al., 2000;
Rodney et al., 2001). In low Ca21, the extent of interaction
was assessed by the disappearance of the free CaM band and
was conﬁrmed by ﬂuorescence (see below). The peptide
C-IQ has the highest apparent afﬁnity for apoCaM but the
IQ peptide shows signiﬁcant binding. No binding of apoCaM
to IQ (AA), C, or A was detected. The IQ to AA mutations in
the CaV1.2 channel destroy Ca
21-dependent inactivation
(Zu¨hlke et al., 1999, 2000) and these changes in the peptide
destroy its ability to bind apoCaM.
The longer peptides have two motifs which, as separate
peptides, both bind CaM. These ﬁndings raise the question of
how many CaMs bind to the longer peptides. In Fig. 1 we
examined the effects of increasing the peptide:CaM ratio on
complex formation. These conditions of peptide in molar
excess would not tend to favor the formation of a complex
with two CaMs bound to one peptide, even if a peptide were
capable of binding two CaMs. If, however, both lobes of
CaM are able to bind to sequences within a peptide, the high
concentrations of peptide might lead to a ternary complex
with two peptides bound to a single molecule of CaM (one
peptide at each lobe). We see no evidence for a complex of
two peptides and one CaM for the A, C, AC, or IQ peptides.
However, at high C-IQ:CaM ratios, there is a loss in the
CaM-peptide complex (Fig. 1 A, lane 8), suggesting that the
two lobes of CaM may each be able to bind a peptide at
this high concentration of peptide. Alternatively, this loss of
the complex from the gels could reﬂect a decrease in the
solubility of the peptide at these high concentrations. A more
important question is whether more than one CaM can bind
to the longer peptides that have two CaM binding motifs. To
address this question we developed a two-dimensional gel
system in which the ﬁrst dimension was a nondenaturing gel
and the second dimension was an SDS gel. Typical two-
dimensional gels (using peptides IQ and C-IQ) are shown in
Fig. 2, A and B. To determine the amount of CaM and
peptide in the two-dimensional gel, an SDS gel, identical to
that used in the second dimension, was created with known
amounts of CaM and peptide (Fig. 2, C and D). Using
densitometric analysis we calculated the molar ratio of CaM
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to peptide in each of the CaM-peptide complexes (Fig. 2 C).
All peptides were tested initially at a CaM:peptide ratio of
1:5, identical to that used in Fig. 1. The longer peptides were
also analyzed under conditions of excess CaM (CaM:peptide
of 5:1). Experiments were also performed with equimolar
ratios of CaM:peptide and gave similar results (data not
shown). The composition of each of the complexes (moles of
CaM per mole peptide) is summarized in Fig. 2 E. At all
CaM:peptide ratios, the complexes were composed of one
molecule of CaM for each molecule of peptide. These
ﬁndings suggest that the different sequences contribute to
a single CaM binding site. In support of this, we recently
determined that the skeletal muscle Cav1.1 channel, which
differs from the cardiac sequence only at a few amino acids
in these regions, binds a single CaM per channel (unpub-
lished observation).
Ca21 concentration dependence of the interaction
of a1 carboxy-terminal peptides with CaM
A number of CaM binding peptides have been shown to
increase the afﬁnity of CaM for Ca21 (Johnson et al., 1996;
Kasturi et al., 1993; Keller et al., 1982; Kilhoffer et al., 1992;
Olwin et al., 1984; Peterson et al., 1999). Peptide C has
a tryptophan that allows its interaction with CaM to be
analyzed by ﬂuorescence. To measure the afﬁnity of CaM for
Ca21 when bound to the IQ region we generated a mutant
peptide (IQW) in which the ﬁrst phenylalanine in the peptide
sequence was mutated to a tryptophan. This mutant IQ
peptide binds Ca21CaM and apoCaM with an apparent
afﬁnity similar to that of the wild-type IQ peptide. The
differences in the ﬂuorescence of these peptides can be used
to analyze the Ca21-concentration dependence of the
FIGURE 1 The interaction of the CaV1.2 channel a1 carboxy-terminal peptides with Ca
21CaM and apoCaM. CaM (2 mM) was incubated with peptide in
increasing peptide:CaMmolar ratios before electrophoresis on 20% nondenaturing gels in the presence of either 200 mMCa21 (A), or 1 mMEGTA (B). Shown
are representative Coomassie-blue stained 20% nondenaturing gels of samples containing CaM and increasing molar ratios of IQ, IQ (AA), C-IQ, C, and A. The
ﬁrst lane in each gel contains CaM only. Peptide:CaM ratios used were 0:1, 0.1:1, 0.5:1, 1:1, 2:1, 3:1, 5:1, 10:1, and 1:0. (C andD) The relative amount of CaM
on the gel at each peptide concentration (B) was determined by densitometry and was normalized to CaM in the absence of peptide (B0). The data are plotted as
the mean B/B06 SE (n¼ 3) vs. peptide:CaM ratio. C summarizes the results from experiments performed in 200 mMCa21 andD summarizes the results from
experiments performed in 1 mM EGTA. The graph shows CaM with increasing peptide concentration described by the following symbols: d, C; }, C-IQ;,,
A; n, IQ; and , IQ (AA).
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interaction of the peptides with CaM. The binding of CaM to
each of the peptides examined in our study produces both
a Ca21-dependent blue shift and an enhancement in the
tryptophan emission spectrum. The interaction of these
peptides with CaM occurs at a lower Ca21concentration than
is required to saturate the lobes of unbound CaM (see below)
indicating that these peptides increase the afﬁnity of CaM for
Ca21 (Fig. 3). Table 2 summarizes the relative afﬁnities of
the Ca21-dependent interaction of these peptides with CaM.
These values were identical using two different excitation/
emission protocols: 1) excitation at 275 nm and emission at
320 nm, and 2) excitation at 295 nm and emission at 330 nm.
Using an excitation of 275 nm and an emission of 320 nm we
can also obtain an estimate of the Ca21 afﬁnity of CaM alone
using tyrosine ﬂuorescence. Under our conditions the EC50
for Ca21 binding to CaM as determined by the change in the
ﬂuorescence of the tyrosine and phenylalanines of CaM with
increasing Ca21 concentrations is 1.2 6 0.3 mM (n ¼ 4).
Tryptophan ﬂuorescence analysis of Ca21 binding
to CaM that is bound to C, IQ, or IQ (AA)
The above peptide ﬂuorescence studies are limited by the
need for a tryptophan in the peptide and cannot be used to
evaluate the binding of Ca21 to the N- and C-lobes of CaM.
One approach to assessing the apparent afﬁnity of the N- and
FIGURE 2 Each peptide binds one mole-
cule of CaM. CaM (2.5 mM or 50 mM) was
incubated with peptide (10 mM) and the
complex was electrophoresed in the ﬁrst
dimension in the nondenaturing gels and in
the second dimension on an SDS Scha¨gger
gel as described in Methods. The gel was
stained with Coomassie blue and the optical
densities of the CaM and peptide spots were
determined by densitometry. In parallel,
a Scha¨gger gel was electrophoresced with
known quantities of CaM and peptide to use
as standard curves for determination of the
amount of peptide and CaM on the two-
dimensional gels. (A) Coomassie-blue stained
two-dimensional gel of CaM 1 peptide IQ
obtained with a 1:5 CaM:peptide ratio. (B)
Coomassie-blue stained two-dimensional gel
of CaM 1 peptide C-IQ obtained with a 1:5
CaM:peptide ratio. (C) Protein standard gel:
Coomassie-blue stained Scha¨gger gel of
known amounts of CaM (20–200 pmoles)
and peptide IQ (20–200 pmoles). (D) Protein
standard gel: Coomassie-blue stained Scha¨g-
ger gel of increasing known amounts of CaM
(20–200 pmoles) and peptide C-IQ (20–200
pmoles). (E) Summary of densitometric
analysis of the two-dimensional gels of the
CaM-peptide complexes. The subscripts on
the peptide name on the x-axis represent the
CaM:peptide ratios used in the incubation
before the ﬁrst-dimension gel. The y-axis
CaM:peptide ratio represents the composition
of the CaM-peptide complexed as assessed on
the second-dimension gel. The data shown
represent data obtained from 3–4 different
two-dimensional gels.
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C-lobes of CaM for Ca21 involves using mutant CaMs in
which a tryptophan has been substituted for a phenylal-
anine at either residue 19 (F19W) or residue 92 (F92W).
Tryptophan residues at these positions are extremely
sensitive to changes in the conformation of CaM that occur
when Ca21 binds to that lobe (Black et al., unpublished data)
and are similar to earlier isofunctional CaMs used to assess
the order of Ca21 binding to CaM (Kilhoffer et al., 1992;
Romanin et al., 2000). We have used F19W and F92W CaM
to assess the effects of the peptides on the apparent afﬁnity of
the N- and C-terminal lobes of CaM for Ca21.
To examine the change in tryptophan ﬂuorescence of
F19W and F92W, we excited at 295 nm and measured
ﬂuorescence at 330 nm. Data comparing IQ to IQ (AA) with
F19W and F92W are shown in Fig. 4, A and B, respectively.
The EC50s are listed in Table 3. The IQ and IQ (AA) peptides
increase the Ca21 afﬁnity of both lobes of CaM as detected
by the leftward shift in the Ca21 dependence of the change in
tryptophan ﬂuorescence for both F19W and F92W. These
ﬁndings suggest that both lobes of CaM are interacting with
both the IQ and IQ (AA) peptides. There are no signiﬁcant
differences in the EC50s for Ca
21 binding to either mutant
CaM bound to the IQ and IQ (AA) peptides. There is,
however, a signiﬁcant increase in ﬂuorescence enhancement
of F92W complexed to IQ (AA) as compared to IQ, sug-
gesting that the interactions of the C-lobe of F92W with the
IQ (AA) peptide are somewhat different than the interactions
of this lobe with the IQ peptide.
We also examined the effects of peptide C on the Ca21
afﬁnity of F19W and F92W. These data are shown in Fig.
4, C and D, respectively. To analyze peptide C’s interactions
with the ﬂuorescent CaMs, we had to consider the
tryptophan in the peptide C sequence, which complicates
the ﬂuorescent signal. To evaluate the contribution of this
tryptophan to the total ﬂuorescence change, we compared the
ﬂuorescence of peptide C obtained with F19W and F92W
with that obtained with wild-type CaM (no tryptophan). The
Ca21-dependent changes in tryptophan ﬂuorescence of
F92W complexed to peptide C occur at approximately the
same Ca21 concentration range as seen with the peptide
bound to wild-type CaM (Fig. 3 D), suggesting that the
interaction is primarily controlled by the C-lobe of CaM. The
titration curve obtained with F19W and peptide C (Fig. 4 C)
is, however, distinctly biphasic. The ﬁrst phase corresponds
to the change in ﬂuorescence of the peptide upon interaction
with the C-lobe of CaM, and the second phase is similar to
the Ca21 dependence for the change in ﬂuorescence of
the N-terminal lobe of F19W in the absence of peptide C.
A similar biphasic curve was obtained with peptide A-C
(summarized in Table 3). Together these data suggest that
either only the C-lobe of Ca21CaM binds to the C and A-C
peptides, or that the interaction of the N-lobe with these
sequences does not alter the Ca21 afﬁnity of this lobe.
In contrast to the ﬁndings with peptides C, A-C, and IQ,
under the conditions of this assay, peptide A does not greatly
alter the afﬁnity of either F19W or F92W for Ca21. Data for
peptide A with F19W and F92W are shown in Fig. 4, E and
F, respectively. We do not detect a change in ﬂuorescence in
either F19W or F92W until the Ca21concentration reaches
a level where the CaMs would bind Ca21 in the absence of
peptide. Upon Ca21 saturation, peptide A binds both F19W
and F92W, producing both an enhancement and a blue shift
in the isofunctional CaM’s tryptophan ﬂuorescence. Since
Ca21 increases the afﬁnity of CaM for the peptide, the
peptide must, therefore, increase the afﬁnity of CaM for
Ca21. This was not detected, suggesting that peptide A must
TABLE 2 EC50 of CaM for Ca21 in the presence of the
CaV1.2 channel peptides
Peptide 1 CaM EC50 for Ca
21
IQW 1 CaM 0.07 6 0.01 mM (n ¼ 3)
C 1 CaM 0.05 6 0.01 mM (n ¼ 8)
C-IQ 1 CaM 0.14 6 0.06 mM (n ¼ 3)
A-C 1 CaM 0.05 6 0.01 mM (n ¼ 3)
CaM 1.2 6 0.3 mM (n ¼ 4)
FIGURE 3 Detection of Ca21-dependent interaction of CaM with the
peptides by tryptophan ﬂuorescence. Using Ca21 standards from Molecular
Probes, the afﬁnity of CaM for Ca21 in the presence of peptide was
determined by measuring an increase in ﬂuorescence emission at 330 nm
after the tryptophan was excited at 295 nm. 2.5 mMCaMwas incubated with
10 mM peptide for one half-hour before the ﬂuorescent studies. The
calculations for afﬁnity are described in Methods. Data are plotted as relative
ﬂuorescence units (RFU) vs. log [Ca21], (A) d, Peptide C 1 CaM; ,
Peptide C alone; and m, CaM alone. (B) d, Peptide IQW 1 CaM; , IQW
alone; and m, CaM alone.
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have a very low afﬁnity for apoCaM and much higher
concentrations of peptide would be required to detect peptide
A effects on the Ca21 afﬁnity of CaM.
Ca21 binding site mutants of CaM as tools to
analyze the interaction of a1 carboxy-terminal
peptides with CaM
The above data suggest that the lobes of CaM have multiple
possible binding sites on the Cav1.2 channel and, therefore,
may move upon binding Ca21. We have used CaM mutants
that cannot bind Ca21 at either the N- or C-lobe to determine
the Ca21 dependence of the interactions with the peptides.
Each CaM mutant has glutamine substitutions in two of the
E-F hands to inactivate Ca21 binding to that lobe of CaM.
These Ca21 binding mutants are E12Q (mutations at both
E31 and E67) and E34Q (mutations at both E104 and E140),
respectively. We tested the interactions of these CaM
mutants with IQ, IQ (AA), A, and C peptides at high Ca21
using gel mobility shift assays as shown in Fig. 5. E12Q
binds to peptides C, IQ, and IQ (AA), but not to the A peptide,
suggesting that Ca21 binding to the N-lobe of CaM is
FIGURE 4 Effect of Ca21 on the interaction of peptides with F19WCaM and F92WCaM. F19W and F92W are CaM mutants that contain an F-to-W
mutation at amino acids 19 and 92, respectively. At different Ca21 concentrations, the tryptophan was excited at 295 nm and the emission in relative
ﬂuorescence (RFU) was detected at 330 nm. Data plotted are the mean of three trials 6 SE. (A) IQ and IQ (AA) with F19W. d, F19W 1 IQ; , F19W 1 IQ
(AA); and n, F19W alone. (B) F92W with IQ and IQ (AA). d, F92W1 IQ; , F92W1 IQ (AA); and n, F92W alone. (C) Peptide C with F19W. d, F19W1 C;
, CaM 1 C; n, C alone; and n, F19W alone. (D) Peptide C with F92W. d, F92W 1 C; , CaM 1 C; n, C alone; and n, F92W alone. (E) Peptide A with
F19W. d, F19W 1 A; m, F19W alone; and n, A alone. (F) Peptide A with F92W. d, F92W 1 A; m, F92W alone; and n, A alone.
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necessary for the interaction of CaM with the A peptide.
E34Q interacts with both IQ and IQ (AA) but has a decreased
afﬁnity for A, C, and A-C. Together these ﬁndings suggest
that the C peptide interaction with CaM is enhanced by Ca21
binding to the C-lobe and the A peptide interaction is
enhanced by Ca21 binding to both lobes of CaM. Several
aspects of the IQ interactions are surprising. Since the IQ
peptide appears to bind both lobes of Ca21CaM (as evi-
denced by the increase in Ca21afﬁnity of both lobes when
bound to IQ), we anticipated a loss of afﬁnity with CaM
mutated in either the N-lobe or C-lobe Ca21 binding sites.
Instead, we found that both E12Q and E34Q bind to both the
IQ and IQ (AA) peptides with apparent afﬁnities similar to
wild-type CaM.
DISCUSSION
Three different sequences in the carboxyterminal tail of the
CaV1.2 channel have been implicated in CaM binding and
in Ca21-dependent inactivation (Peterson et al., 1999; Pate
et al., 2000; Zu¨hlke et al., 2000; Pitt et al., 2001). We have
compared the ability of peptides matching these sequences in
the CaV1.2 channel to bind Ca
21CaM, apoCaM, and Ca21
binding site mutants of CaM and to alter the Ca21afﬁnity of
CaM.
We conﬁrm that all three sequences (A, C, and IQ) bind
Ca21CaM. Peterson et al. (1999) showed that a mutant CaM
that does not bind Ca21 at any of its four sites blocks the
ability of Ca21CaM to produce inactivation, suggesting that
the channel binds apoCaM and that Ca21 binding to CaM is
required for Ca21-dependent inactivation. More speciﬁcally,
this group showed that Ca21 binding to sites 3 and 4 at the
C-lobe of CaM is required for Ca21-dependent inactivation
(Peterson et al., 1999; Alseikhan et al., 2002). Our com-
parison of the ability of the different peptides to bind
apoCaM, E12Q, and E34Q offers some possible explana-
tions for these observations. The IQ peptide alone binds
apoCaM whereas the A and C peptides do not. The C-IQ
peptide, however, binds apoCaM with higher apparent af-
ﬁnity than IQ alone. We propose that the C-IQ region on the
carboxyl terminal tail of the a1 subunit of the Cav1.2 channel
is a candidate for the apoCaM binding site on the channel.
CaM mutated at Ca21 binding sites 1 and 2 in the N-lobe
of CaM (E12Q) binds to the IQ and C peptides, but not to the
A peptide. CaM mutated at Ca21 binding sites 3 and 4 in the
C-lobe of CaM binds to the IQ peptide, but not to the C or A
peptides. The mutations in CaM that abolish inactivation,
therefore, appear to correlate with the changes in its
interactions with the A and C peptides.
Our ﬁndings suggest that the IQ peptide can interact with
CaM in a variety of states: Ca21 free, Ca21 bound only at the
N-lobe, Ca21 bound only at the C-lobe, and fully Ca21
bound. In contrast, the C peptide can bind CaM with its
N-lobe Ca21 free and its C-lobe Ca21 bound or with both
lobes Ca21 bound. The A peptide requires Ca21 binding to
both lobes of CaM for interaction. These ﬁndings are
consistent with the effects of the peptides on the Ca21
afﬁnity of the lobes of CaM. The IQ peptide increases the
afﬁnity of both the N- and C-lobes of CaM for Ca21,
suggesting an interaction with both lobes. In contrast, the
C peptide increases the Ca21afﬁnity of only the C-lobe of
CaM. The A peptide, however, appears to have a low afﬁnity
for apoCaM and a higher afﬁnity for Ca21CaM. The low
afﬁnity for apoCaM suggests that higher concentrations of
peptide A would be required to see an affect on Ca21 afﬁnity
of CaM. One possible explanation of the ability of CaM
mutated at Ca21 binding sites 3 and 4 to block Ca21-
dependent inactivation (Peterson et al., 1999; Alseikhan et al.,
2002) is that these mutations in CaM alter its interactions
with the A-C sequence.
Ca21-dependent inactivation of the channel can also be
abolished by the mutation of the isoleucine and glutamine
residues of the IQ motif in the channel to alanines (Zu¨hlke
et al., 2000). These mutations in the synthetic IQ peptide do
not alter the apparent afﬁnity of the peptide for Ca21CaM,
the apparent afﬁnity of the CaM for Ca21, or the apparent
afﬁnity for interactions of the peptide with either E12Q or
E34Q. The latter ﬁnding is somewhat surprising if both lobes
of CaM interact with IQ. There are several possible
explanations of the lack of a major effect of the Ca21
binding site mutations on the interaction with IQ: 1), when
one lobe binds IQ in the Ca21 bound state the other lobe can
still bind in the Ca21 free state and any apparent afﬁnity
differences are small; 2), there is only a single site on the IQ
motif for interaction with a lobe of CaM and this site can
engage either the N- or the C-lobe of Ca21CaM with equal
afﬁnity; 3) the afﬁnity for a Ca21 bound lobe is greater in the
absence of Ca21 binding to the second lobe; or 4) the IQ
peptide is interacting with a region on CaM that is exposed
by Ca21 binding to either the N- or C-lobes. The ﬁrst
TABLE 3 EC50 of F19WCaM and F92WCaM for Ca21 in the
presence of the CaV1.2 channel peptides
Peptide 1 CaM EC50 for Ca
21 (mM)
A 1 F19W 3.7 6 0.8 (n ¼ 5)
A 1 F92W 2.1 6 0.2 (n ¼ 5)
C 1 F19W 0.05 6 0.03
8 6 5 (n ¼ 3)
C 1 F92W 0.06 6 0.04 (n ¼ 3)
IQ 1 F19W 0.03 6 0.01 (n ¼ 8)
IQ 1 F92W 0.05 6 0.01 (n ¼ 9)
A-C 1 F19W 0.1
2.3 (n ¼ 2)
A-C 1 F92W 0.13 6 0.04 (n ¼ 3)
C-IQ 1 F19W 0.08 (n ¼1)
C-IQ 1 F92W 0.08 (n ¼ 1)
IQ (AA) 1 F19W 0.05 6 0.01 (n ¼ 5)
IQ (AA) 1 F92W 0.05 6 0.01 (n ¼ 6)
F19W 2.1 6 0.4 mM (n ¼ 6)
F92W 0.8 6 0.1 mM (n ¼ 6)
All peptides were tested at a peptide:CaM ratio of 5:1.
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possibility seems unlikely since the IQ (AA) mutation greatly
decreases apoCaM binding, but shows normal binding of
E12Q and E34Q under conditions where one lobe is Ca21
bound. We think the most likely explanation is that only one
lobe of Ca21CaM is binding to the IQ peptide and this can be
either Ca21-bound lobe. This could be a phenomenon that
does not occur in the native channel but is rather found only
with using isolated peptides and CaM at high concentrations.
Alternatively, this type of lobe equivalence for CaM in-
teraction with the IQ motif interaction in the native channel
could contribute to the complexity of the modulation of this
channel by CaM.
Another issue addressed in this manuscript is how many
CaMs bind to a peptide that has more than one of these
binding motifs. We ﬁnd that the A-C and C-IQ peptides bind
only a single molecule of CaM, suggesting that the three
sequences are likely to contribute to a single CaM binding
site and that the lobes of CaM can move within the site.
In summary we have shown that, 1), the C-IQ peptide
binds apoCaM; 2), the IQ peptide increases the Ca21 afﬁnity
of both the N- and C-lobes of CaM, but can bind CaM with
only one lobe (either one) Ca21 bound; 3), the C peptide
increases the Ca21 afﬁnity of only the C-lobe of CaM and
has decreased afﬁnity for a CaM that cannot bind Ca21 at its
C-lobe; and 4), the IQ to AA mutation that, in the channel,
abolishes Ca21-dependent inactivation, primarily alters the
ability of the IQ peptide to bind apoCaM. The ability of the
Ca21 binding state of CaM to regulate its interactions with
the different sequences may suggest mechanisms whereby
this molecule can function in different regulatory roles on the
channel. A model consistent with our peptide data is that
apoCaM binds to the C-IQ region of the channel and this
interaction is required for Ca21-dependent inactivation.
Upon an increase in cytoplasmic Ca21 concentration, Ca21
binding to the C-lobe of CaM may favor its movement to the
A-C region, leading to Ca21-dependent inactivation.
FIGURE 5 Interaction of E12Q and E34QCaMs with the cardiac CaV1.2 channel peptides A,C, IQ, and IQ (AA). CaM (3mM)was incubated with peptide in
increasing peptide:CaM molar ratios before electrophoresis on 20% nondenaturing gels (added 200 mM Ca21). (A and B) The representative Coomassie-blue
stained 20% nondenaturing gels of samples containing E12Q CaM (A) or E34Q CaM (B) and increasing molar ratios of IQ, IQ (AA), C, and A are evaluated.
Ratios of peptide:CaM (beginning in lane 2) are 0:1, 0.1:1, 0.5:1, 1:1, 2:1, 3:1, 5:1, 10:1, and 1:0. (C and D) The optical density of the CaM band on the gel in
the presence of increasing peptide (B) was determined by densitometry and was normalized to the optical density of the CaM band in the absence of peptide
(B0). The data are plotted as the mean B/B06 SE (n > 3) vs. peptide:CaM ratio. (C) Summary of data with E12Q. d, C1 E12Q;n, IQ1 E12Q; , IQ (AA)1
E12Q; and ,, A 1 E12Q. (D) Summary of data with E34Q. d, C 1 E34Q; n, IQ 1 E34Q; , IQ (AA) 1 E34Q; and ,, A 1 E34Q.
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